What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to publicly disclose material information regarding certain settlement agreements entered into by HCA Healthcare, Inc., in compliance with Regulation FD.

Where can I find the details of the settlement agreements?

The specific details of the settlement agreements are not fully elaborated in the 8-K text itself. Investors are directed to review Exhibit 99, which contains the full press release issued by HCA on June 26, 2003, detailing these agreements.

What is Regulation FD and why is it relevant here?

Regulation FD (Fair Disclosure) requires public companies to disseminate material information broadly and non-selectively. This 8-K filing, under Item 9, is being made to comply with Regulation FD, ensuring that the information about the settlement agreements is made available to all investors simultaneously, rather than selectively to a few.

What financial or operational impact should investors anticipate from these settlements?

The 8-K itself does not detail the financial or operational impact. Investors must refer to the press release in Exhibit 99 for information on potential costs, penalties, changes in business practices, or other consequences arising from the settlement agreements.

HCA 8-K SEC Disclosure — Jun 30, 2003

Summary

HCA Healthcare, Inc. (HCA) filed an 8-K on June 29, 2003, to report significant updates regarding settlement agreements. The company issued a press release on June 26, 2003, detailing these agreements, which are crucial for investors to understand the potential financial and operational impacts. This filing falls under Regulation FD disclosures, ensuring that material information is broadly disseminated to the public. While the specific details of the settlements are not included within the 8-K text itself, the filing points to Exhibit 99, which contains the full press release. Investors should carefully review this press release for comprehensive information regarding the nature of the settlements, any associated financial implications (such as fines, penalties, or legal costs), and HCA's strategic outlook following these agreements. This information is vital for assessing the company's risk profile and future performance.

Key Highlights

1HCA Healthcare filed an 8-K on June 29, 2003, reporting on settlement agreements.
2The event date triggering this filing was June 25, 2003.
3The filing is made under Regulation FD (Fair Disclosure), ensuring broad dissemination of material information.
4Key details of the settlement agreements are provided in an attached press release (Exhibit 99).
5Investors are directed to Exhibit 99 for comprehensive information on the settlements.
6The press release was issued on June 26, 2003, shortly before the 8-K filing.

HCA Healthcare, Inc. 8-K Report (Jun 30, 2003)

Summary

Key Highlights

Frequently Asked Questions